InvestorsHub Logo
Followers 154
Posts 2652
Boards Moderated 0
Alias Born 01/29/2004

Re: Investor2014 post# 347487

Monday, 01/31/2022 2:39:42 PM

Monday, January 31, 2022 2:39:42 PM

Post# of 463606
Rett, only?

We don't need A2-73 for COVID, we need it now first for Rett if it works!!!


Why just Rett "now?" The number of girls with Rett is a fraction (tiny) of people with Parkinson's and Alzheimer's diseases.

Or, are you presuming blarcamesine (Anavex 3-73) must first "prove" itself on some lesser central nervous system disease before it can even be considered for the two biggies, Parkinson's and Alzheimer's?

Were they to know the evidence for blarcamesine efficacy and safety against Parkinson's and Alzheimer's, people (and caregivers) with those diseases would inveigh a similar "now" immediacy for blarcamesine.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News